Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 05/17/18 → 01/4/20 |
Funding
- Janssen Research and Development LLC: $9,600.00
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized...
- Nachman, Sharon (PI)
- Beneri, Christy (CoPI)
- Hymes, Saul (CoPI)
Project: Research